Globalisation and clinical trial supply markets
Globalisation is undoubtedly a buzzword in today’s business environment, but what does it actually mean? Robert Donnell, head of business development at Durbin, looks at how it...
Use your leftovers: answers for excess stock
The size, complexity and geographical distribution of clinical trials can often lead to stock being left over, either at specific sites during the trial or overall following...
Global reach
The clinical trials supply market is becoming increasingly complex. Robert Donnell, head of business development at Durbin, talks to Clinical Trials Insight about the company’s network...
